RedHawk Holdings Corp (fka SNDD)

[king koopa]

I like this statement from the last Q:

Revenues in the pharmaceutical and medical device business unit are expected to improve as market acceptance of our products increases. Additionally, net profits are expected to improve as the Company’s pharmaceutical sales become more weighted to its branded generics which offer lower discounts than the discounts offered by the Company for its highly competitive “special” pharmaceuticals and require significantly lower operating costs.